These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20685035)

  • 1. Antagonists of IAP proteins as cancer therapeutics.
    Dynek JN; Vucic D
    Cancer Lett; 2013 May; 332(2):206-14. PubMed ID: 20685035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitor of apoptosis (IAP) proteins: novel insights into the cancer-relevant targets for cell death induction.
    Fulda S
    ACS Chem Biol; 2009 Jul; 4(7):499-501. PubMed ID: 19588916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.
    Varfolomeev E; Blankenship JW; Wayson SM; Fedorova AV; Kayagaki N; Garg P; Zobel K; Dynek JN; Elliott LO; Wallweber HJ; Flygare JA; Fairbrother WJ; Deshayes K; Dixit VM; Vucic D
    Cell; 2007 Nov; 131(4):669-81. PubMed ID: 18022362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting inhibitor of apoptosis proteins for therapeutic intervention.
    Ndubaku C; Cohen F; Varfolomeev E; Vucic D
    Future Med Chem; 2009 Nov; 1(8):1509-25. PubMed ID: 21426063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy.
    de Almagro MC; Vucic D
    Exp Oncol; 2012 Oct; 34(3):200-11. PubMed ID: 23070005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibitor of apoptosis proteins as therapeutic targets in cancer.
    Vucic D; Fairbrother WJ
    Clin Cancer Res; 2007 Oct; 13(20):5995-6000. PubMed ID: 17947460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of immune signalling by inhibitors of apoptosis.
    Beug ST; Cheung HH; LaCasse EC; Korneluk RG
    Trends Immunol; 2012 Nov; 33(11):535-45. PubMed ID: 22836014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma.
    Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Yeap BY; Sugarbaker DJ; Bueno R
    J Pathol; 2007 Mar; 211(4):439-46. PubMed ID: 17253597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IAP-targeted therapies for cancer.
    LaCasse EC; Mahoney DJ; Cheung HH; Plenchette S; Baird S; Korneluk RG
    Oncogene; 2008 Oct; 27(48):6252-75. PubMed ID: 18931692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of c-IAP and XIAP proteins is required for efficient induction of cell death by small-molecule IAP antagonists.
    Ndubaku C; Varfolomeev E; Wang L; Zobel K; Lau K; Elliott LO; Maurer B; Fedorova AV; Dynek JN; Koehler M; Hymowitz SG; Tsui V; Deshayes K; Fairbrother WJ; Flygare JA; Vucic D
    ACS Chem Biol; 2009 Jul; 4(7):557-66. PubMed ID: 19492850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitor of Apoptosis (IAP) proteins as therapeutic targets for radiosensitization of human cancers.
    Fulda S
    Cancer Treat Rev; 2012 Oct; 38(6):760-6. PubMed ID: 22342104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis.
    Vince JE; Wong WW; Khan N; Feltham R; Chau D; Ahmed AU; Benetatos CA; Chunduru SK; Condon SM; McKinlay M; Brink R; Leverkus M; Tergaonkar V; Schneider P; Callus BA; Koentgen F; Vaux DL; Silke J
    Cell; 2007 Nov; 131(4):682-93. PubMed ID: 18022363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death.
    Li L; Thomas RM; Suzuki H; De Brabander JK; Wang X; Harran PG
    Science; 2004 Sep; 305(5689):1471-4. PubMed ID: 15353805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting IAP (inhibitor of apoptosis) proteins for therapeutic intervention in tumors.
    Vucic D
    Curr Cancer Drug Targets; 2008 Mar; 8(2):110-7. PubMed ID: 18336193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy.
    Knights AJ; Fucikova J; Pasam A; Koernig S; Cebon J
    Cancer Immunol Immunother; 2013 Feb; 62(2):321-35. PubMed ID: 22923192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitor of apoptosis proteins: fascinating biology leads to attractive tumor therapeutic targets.
    Varfolomeev E; Vucic D
    Future Oncol; 2011 May; 7(5):633-48. PubMed ID: 21568679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Livin/ML-IAP as a new target for cancer treatment.
    Liu B; Han M; Wen JK; Wang L
    Cancer Lett; 2007 Jun; 250(2):168-76. PubMed ID: 17218055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathways: targeting inhibitor of apoptosis proteins in cancer--from molecular mechanism to therapeutic application.
    Fulda S
    Clin Cancer Res; 2014 Jan; 20(2):289-95. PubMed ID: 24270683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploiting inhibitor of apoptosis proteins as therapeutic targets in hematological malignancies.
    Fulda S
    Leukemia; 2012 Jun; 26(6):1155-65. PubMed ID: 22230799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2(1).
    Blankenship JW; Varfolomeev E; Goncharov T; Fedorova AV; Kirkpatrick DS; Izrael-Tomasevic A; Phu L; Arnott D; Aghajan M; Zobel K; Bazan JF; Fairbrother WJ; Deshayes K; Vucic D
    Biochem J; 2009 Jan; 417(1):149-60. PubMed ID: 18939944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.